ResMed Inc logo

ResMed Inc

A$ 35.61 (+3.37%) Oct 5
P/E:
43.23
P/B:
10.00
Market Cap:
A$ 51.15B ($ 33.06B)
Enterprise V:
A$ 52.16B ($ 33.70B)
Volume:
1.73M
Avg Vol (2M):
1.15M
Also Trade In:
Volume:
1.73M
Market Cap A$:
51.15B
Market Cap $:
33.06B
PE Ratio:
43.23
Avg Vol (2-Month):
1.15M
Enterprise Value A$:
52.16B
Enterprise Value $:
33.70B
PB Ratio:
10.00
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Financials (Next Earnings Date:2022-10-28 Est.)

ASX:RMD's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 4,961.659
EPS (TTM) (A$) 0.736
Beta 0.23
Volatility % 22.82
14-Day RSI 67.52
14-Day ATR (A$) 0.664142
20-Day SMA (A$) 33.776
12-1 Month Momentum % -9.45
52-Week Range (A$) 27.37 - 38.41
Shares Outstanding (Mil) 1,464.25

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ResMed Inc Filings

Document Form Filing Date
No Filing Data

ResMed Inc Analysis

Share your research